This sector includes a wide-variety of issuers. Included in this group are companies involved in Financial Services, Real Estate, Media, Consumer and Industrial Products.
Beyond Oil is a food-tech innovative company that has developed a unique patented breakthrough solution to eliminate Free Fatty Acids (FFA) from oils through a green and cost effective process.
BIOSENTA Inc.'s line of retail anti-microbial products will effectively kill mould, bacteria and fungi on contact and prevent re-growth. These products address the demand created by the mounting health and environmental concerns. BIOSENTA will also manufacture and distribute an anti-microbial filler.
Birchtree Investments Ltd. is an investment company with the long-term goal of divesting its investment assets at a profit. The Issuer plans to invest opportunistically, making use of the experience and contacts of its Board and management to identify promising investments at a stage of development where the Issuer will be able to play a role in the success of the investment. The Issuer’s focus is on (i) early stages of a target company’s development, (ii) technologies that are developed and validated but may be in the early stage of commercialization, or (iii) target companies that require strategic guidance and thus are undervalued. The Issuer has made initial investments in 7 companies.
Blackhawk Growth Corp. is a growing public investment fund located in Calgary, AB. Blackhawk drives its growth by investing in equity and debt instruments of companies and generating positive returns with minimal risk for shareholders. The company's strategy is focused on investing in multiple companies across a variety of sectors across North America.
Blackhawk Growth Corp. is a growing public investment fund located in Calgary, AB. Blackhawk drives its growth by investing in equity and debt instruments of companies and generating positive returns with minimal risk for shareholders. The company's strategy is focused on investing in multiple companies across a variety of sectors across North America.
Blender Bites is a Canadian company involved in the development and marketing of a line of premium frozen food products with a focus on functionality. Blender Bites was founded in 2016 and sells a pre-portioned “easy smoothie” product that is free of any unnecessary inner plastic packaging. Blender Bites products are organic, vegan, non-GMO, gluten free, dairy free and soy free. They contain no added sugars and are made in Canada. Blender Bites products are distributed nationally across Canada and are currently sold in over 800 stores, including Sobeys, Safeway, Save on Foods, Whole Foods Market, Buy-Low/Nesters, IGA and Fresh Street, with a launch planned into the United States marketplace. Blender Bites anticipates expanding its plant-based footprint in North America through organic growth of the existing brand and through new acquisitions.
Listed on the Canadian Securities Exchange under the trading symbol “BTC” and "BTC.PR.A" and in the United States on the OTC Markets under the trading symbol "BTCWF", Bluesky Digital Assets Corp, is building a high value digital enterprise focused on Artificial Intelligence ("AI") based Blockchain technology. Bluesky takes an approach that enables the Corporation to scale, and respond to changing conditions, within the still-emerging Blockchain industry.The Corporation is poised to capture value in successive phases as this industry continues to change, evolve, and scale. For more information please visit Bluesky at: www.blueskydigitalassets.com or www.blueskyintel.com
Please also follow us on Linkedin at: www.linkedin.com/company/bluesky-digital-assets/
Listed on the Canadian Securities Exchange under the trading symbol “BTC” and "BTC.PR.A" and in the United States on the OTC Markets under the trading symbol "BTCWF, Bluesky Technologies Corp., is building a high value digital currency enterprise.
Bluesky mines digital currencies, such as Bitcoin and Ether, and is developing value-added technology services for the digital currency market, such as proprietary technology solutions.
Offering a complete ecosystem of value-creation, Bluesky is targeting reinvesting appropriate portions of its digital currency mining profits back into its operations. A percentage of the profit will be invested in the development of a proprietary Artificial Intelligence ("AI") based technology.
Overall, Bluesky takes an approach that enables the Corporation to scale, and respond to changing conditions, within the still-emerging Blockchain industry. The Corporation is poised to capture value in successive phases as this industry continues to scale.
For more information please visit www.blueskydigitalassets.com
Link to Bluesky Digital Assets Corp. primary CSE Listing Page
Braxia Scientific Corp. is a medical solutions company that aims to reduce the illness burden of brain-based mental disorders (e.g., major depressive disorder). Its operations are primarily focused on (i) owning and operating multidisciplinary clinics providing treatment for mental health disorders and (ii) research activities related to discovering and commercializing novel drugs and delivery methods.
Braxia Scientific develops ketamine and psilocybin derivatives and other psychedelic products from the Company’s IP development platform. Braxia Scientific, through Braxia Health, operates multidisciplinary community-based clinics offering rapid-onset treatments for depression located in Mississauga, Toronto, Ottawa, Kitchener and Montreal.
Britannia Life Sciences Inc. is a global product development platform offering an integrated suite of products to assist companies along their product development journey. Britannia's services, including product formulations, safety assessments, analytical and microbiological testing, global compliance and consumer evaluations are offered to companies ranging from multinationals to startups particularly in the cosmetics, food and wellness industries. Britannia has garnered significant expertise in the development and regulatory approval of topical and edible cannabis products, including preparation and support for novel food authorizations.
